Caliway Biopharmaceuticals Co., Ltd. (TPE:6919)
142.00
-7.50 (-5.02%)
Mar 4, 2026, 12:50 PM CST
51.39% (1Y)
| Market Cap | 231.72B |
| Revenue (ttm) | 34.99M |
| Net Income (ttm) | -488.25M |
| Shares Out | 1.55B |
| EPS (ttm) | -0.32 |
| PE Ratio | n/a |
| Forward PE | 62.55 |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 5,577,348 |
| Average Volume | 7,281,932 |
| Open | 147.00 |
| Previous Close | 149.50 |
| Day's Range | 141.50 - 147.50 |
| 52-Week Range | 54.10 - 277.00 |
| Beta | 0.55 |
| RSI | 41.09 |
| Earnings Date | Feb 6, 2026 |